Juglanin induces apoptosis and autophagy in human breast cancer progression via ROS/JNK promotion

Biomedicine and Pharmacotherapy

Volumn 85, Issue , 2017, Pages 303-312

  Sun, Zhu Lei ^a   Dong, Jin Long ^a   Wu, Jiang ^a  

^a HENAN UNIVERSITY   (China)

Author keywords

Apoptosis; Autophagy; Breast cancer; Juglanin; ROS JNK

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 8; CASPASE 9; CHECKPOINT KINASE 2; CYCLIN D; CYCLIN DEPENDENT KINASE 1; JUGLANIN; NATURAL PRODUCT; PROTEIN P27; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; CASPASE; GLYCOSIDE; KAEMPFEROL DERIVATIVE; MAP1LC3B PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN KINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; APOPTOSIS ASSAY; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY ASSAY; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; M PHASE CELL CYCLE CHECKPOINT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR VOLUME; UPREGULATION; WALNUT; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BREAST NEOPLASMS; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; ENZYMOLOGY; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; MCF-7 CELL LINE; METABOLISM; NUDE MOUSE; OXIDATIVE STRESS; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TIME FACTOR;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; BREAST NEOPLASMS; CASPASES; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FEMALE; G2 PHASE CELL CYCLE CHECKPOINTS; GLYCOSIDES; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KAEMPFEROLS; MALE; MCF-7 CELLS; MICE, INBRED BALB C; MICE, NUDE; MICROTUBULE-ASSOCIATED PROTEINS; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85007413659     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.11.030     Document Type: Article

References (35)

1. [1] Perou, C.M., Sorlie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S., Rees, C.A., Pollack, J.R., Ross, D.T., Johnsen, H., Akslen, L.A., et al. Molecular portraits of human breast tumors. Nature 406 (2000), 747–752.
2. [2] Sethi, S., Sarkar, F.H., Ahmed, Q., Bandyopadhyay, S., Nahleh, Z.A., Semaan, A., Sarkr, W., Munkarah, A., Ali-Fehmi, R., Molecular markers of epithelial-to mesenchymal transition are associated with tumor aggressiveness in breast carcinoma. Translational. Oncol. 4 (2011), 222–226.
3. [3] Blick, T., Widodo, E., Hugo, H., Waltham, M., Lenburg, M.E., Neve, R.M., Thompson, E.W., Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin. Exp. Metastasis 25 (2008), 629–642.
4. [4] Montagna, E., Cancello, G., D'Agostino, D., Lauria, R., Forestieri, V., Esposito, A., Silvestro, L., Accurso, A., de Placido, S., de Laurentiis, M., Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab. Cancer Chemother. Pharmacol. 63 (2009), 275–280.
5. [5] Christofori, G., Bill, R., The relevance of EMT in breast cancer metastasis: correlation or causality. FEBS 589 (2015), 1577–1587.
6. [6] O'shaughnessy, J., Schwartzberg, L., Danso, M.A., Miller, K.D., Rugo, H.S., Neubauer, M., Robert, N., Hellerstedt, B., Saleh, M., Richards, P., et al. Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer. J. Clin. Oncol. 32 (2014), 3840–3847.
7. [7] Zhou, G.Y., Yi, Y.X., Jin, L.X., Lin, W., Fang, P.P., Lin, X.Z., et al. Inhibitory effects of juglanin on cellular senescence in human dermal fibroblasts. Biomed. Pharmacother. 81 (2016), 318–328.
8. [8] Yang, H.H., Hwangbo, K., Zheng, M.S., Son, J.K., Kim, H.Y., Baek, S.H., et al. Inhibitory effects of juglanin on cellular senescence in human dermal fibroblasts. J. Nat. Med. 68 (2014), 473–480.
9. [9] Kim, H.H., Oh, M.H., Park, K.J., Heo, J.H., Lee, M.W., Anti-inflammatory activity of sulfate-containing phenolic compounds isolated from the leaves of Myrica rubra. Fitoterapia 92 (2014), 188–193.
10. [10] Wu, T.Y., Saw, C.L., Khor, T.O., Pung, D., Boyanapalli, S.S., Kong, A.N., In vivo pharmacodynamics of indole-3-carbinol in the inhibition of prostate cancer in transgenic adenocarcinoma of mouse prostate (TRAMP) mice: involvement of Nrf2 and cell cycle/apoptosis signaling pathways. Mol. Carcinog. 51 (2012), 761–770.
11. [11] Li, J.P., Yang, Y.X., Liu, Q.L., Pan, S.T., He, Z.X., Zhang, X., Yang, T., Chen, X.W., Wang, D., Qiu, J.X., et al. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. J. Drug Des. Dev. Ther. 9 (2015), 1627–1652.
12. [12] Clemens, D.L., Schneider, K.J., Nuss, R.F., Ethanol metabolism activates cell cycle checkpoint kinase, Chk2. Alcohol 45 (2011), 785–793.
13. [13] Atherton-Fessler, S., Parker, L.L., Geahlen, R.L., Piwnica-Worms, H., Mechanisms of p34cdc2 regulation. Mol. Cell. Biol. 13 (1993), 1675–1685.
14. [14] Hoek, J.B., Pastorino, J.G., Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol 27 (2002), 63–68.
15. [15] San-Miguel, B., Crespo, I., Vallejo, D., Álvarez, M., Prieto, J., González-Gallego, J., Tuñón, M.J., Melatonin modulates the autophagic response in acute liver failure induced by the rabbit hemorrhagic disease virus. J. Pineal Res. 56 (2014), 313–321.
16. [16] Kim, Y.C., Guan, K.L., mTOR: A pharmacologic target for autophagy regulation. J. Clin. Investig. 125 (2015), 25–32.
17. [17] Filomeni, G., de Zio, D., Cecconi, F., Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ. 22 (2015), 377–388.
18. [18] Filomeni, G., de Zio, D., Cecconi, F., Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ. 22 (2015), 377–388.
19. [19] Dhillon, A.S., Hagan, S., Rath, O., Kolch, W., MAP kinase signalling pathways in cancer. Oncogene 26 (2007), 3279–3290.
20. [20] Liu, Q.R., Liu, J.M., Chen, Y., Xie, X.Q., Xiong, X.X., Qiu, X.Y., Pan, F., Liu, D., Yu, S.B., Chen, X.Q., Piperlongumine inhibits migration of glioblastoma cells via activation of ROS-dependent p38 and JNK signaling pathways. Oxid. Med. Cell. Longev., 2014, 2014, 653732.
21. [21] Goldsmith, E.J., Min, X., He, H., Zhou, T., Structural studies of MAP Kinase cascade components. Methods Mol. Biol. 661 (2010), 223–237.
22. [22] Huang, C., Jacobson, K., Schaller, M.D., A role for JNK-paxillin signaling in cell migration. ABBV Cell Cycle 3 (2004), 4–6.
23. [23] Mallini, P., Lennard, T., Kriby, J., Meeson, A., Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance. Cancer Treat. Rev. 40 (2014), 341–348.
24. [24] Cheng, Q., Chang, J.T., Gwin, W.R., Zhu, J., Ambs, S., Geradts, J., Lyerly, H.K., A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype. Breast Cancer Res., 16, 2014, 407.
25. [25] Lu, Y.J., Yang, S.H., Chien, C.M., Lin, Y.H., Hu, X.W., Wu, Z.Z., Wu, M.J., Lin, S.R., Induction of G2/M phase arrest and apoptosis by a novel enediyne derivative THDB, in chronic myeloid leukemia (HL-60) cells. Toxicol. in Vitro 21 (2007), 90–98.
26. [26] Lu, Y.J., Yang, S.H., Chien, C.M., Lin, Y.H., Hu, X.W., Wu, Z.Z., Wu, M.J., Lin, S.R., Induction of G2/M phase arrest and apoptosis by a novel enediyne derivative THDB, in chronic myeloid leukemia (HL-60) cells. Toxicol. in Vitro 21 (2007), 90–98.
27. [27] Zhan, Y., Chadee, D.N., Inhibition of Cdc42-mediated activation of mixed lineage kinase 3 by the tumor suppressor protein merlin. Small GTPases 1 (2010), 183–186.
28. [28] Clemens, D.L., Schneider, K.J., Nuss, R.F., Ethanol metabolism activates cell cycle checkpoint, Chk2 kinase. Alcohol 45 (2011), 785–793.
29. [29] Du, Y., Bock, B.C., Schachter, K.A., Chao, M., Gallo, K.A., Cdc42 induces activation loop phosphorylation and membrane targeting of mixed lineage kinase 3. J. Biol. Chem. 280 (2005), 42984–42993.
30. [30] Pessayre, D., Mansouri, A., Berson, A., Fromentry, B., Mitochondrial involvement in drug-induced liver injury. Handb. Exp. Pharmacol. 196 (2010), 311–365.
31. [31] Gross, A., Bcl-2 family proteins as regulators of mitochondria metabolism. Biochim. Biophys. Acta 2016 (1857), 1243–1246.
32. [32] Adams, J.M., Cory, S., The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26 (2007), 1324–1337.
33. [33] Jiang, X., Overholtzer, M., Thompson, C.B., Autophagy in cellular metabolism and cancer. J. Clin. Investig. 125 (2015), 47–54.
34. [34] Simon, H.U., Haj-Yehia, A., Levi-Schaffer, F., Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5 (2000), 415–418.
35. 2+, ROS, JNK P38, matrix metalloproteinase 2 and migration related reelin protein. Pestic. Biochem. Physiol. 111 (2014), 51–59.